II. Details: Therapeutic Agents for Chronic Heart Failure; 3. Diuretics
Author:
Affiliation:
1. Department of Cardiovascular Biology and Medicine, Niigata University School of Medical and Dental Sciences
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/naika/111/2/111_235/_pdf
Reference10 articles.
1. 1) Ambrosy AP, et al: Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34: 835-843, 2013.
2. 2) Hasselblad V, et al: Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9: 1064-1069, 2007.
3. 3) Walma EP, et al: Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. BMJ 315: 464-468, 1997.
4. 4) Ferreira JP, et al: Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors. Clin Res Cardiol 102: 745-753, 2013.
5. 5) Konstam MA, et al: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297: 1319-1331, 2007.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3